The onset of malignant hyperthermia in a patient during a prolonged anaesthetic for tumour resection is described. The onset was delayed with a gradual rise in heart rate and PETCO2 before becoming fulminant; muscle rigidity was not a feature. Other aspects of the patient’s condition confused the presentation, delayed the diagnosis and may have been involved in precipitating the event. However, it responded rapidly to treatment and surgery was continued. A possible recrudescence occurred 18 h later. Malignant hyperthermia should be considered early in cases of unexplained tachycardia or rising PETCO2
\s=b\Malignant hyperthermia is an autoso-mal dominant disorder with variable expressivity that is ca...
Malignant hyperthermia is a serious anesthetic complication, presenting with various manifestations,...
Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by volatile an...
Background: The initial presentation of malignant hyperthermia (MH) may begin in the postoperative p...
AbstractCharacteristic signs of malignant hyperthermia (MH) include unexplained tachycardia, increas...
Characteristic signs of malignant hyperthermia (MH) include unexplained tachycardia, increased end-t...
Detailed reports are presented of two cases of malignant hyperpyrexia occurring in two males. Both p...
Malignant hyperthermia (MH) can develop after contact with volatile anesthetics (halothane, enfluran...
Copyright © 2014 Michihiro Sakai et al.This is an open access article distributed under theCreative ...
Malignant hyperthermia manifests clinically as a hypermetabolic crisis when a malignant hyperthermia...
Malignant hyperthermia is a subclinical myopathy, usually triggered by anesthetics and associated wi...
Modern anaesthetic techniques have resulted in the clinical presentation of malignant hyperthermia t...
Copyright © 2013 K. Sanem Cakar Turhan et al.This is an open access article distributed under the Cr...
Malignant hyperthermia is a subclinical myopathy in which general anesthesia triggers an uncontrolla...
ObjectivesMalignant hyperthermia susceptibility is an important risk factor during general anesthesi...
\s=b\Malignant hyperthermia is an autoso-mal dominant disorder with variable expressivity that is ca...
Malignant hyperthermia is a serious anesthetic complication, presenting with various manifestations,...
Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by volatile an...
Background: The initial presentation of malignant hyperthermia (MH) may begin in the postoperative p...
AbstractCharacteristic signs of malignant hyperthermia (MH) include unexplained tachycardia, increas...
Characteristic signs of malignant hyperthermia (MH) include unexplained tachycardia, increased end-t...
Detailed reports are presented of two cases of malignant hyperpyrexia occurring in two males. Both p...
Malignant hyperthermia (MH) can develop after contact with volatile anesthetics (halothane, enfluran...
Copyright © 2014 Michihiro Sakai et al.This is an open access article distributed under theCreative ...
Malignant hyperthermia manifests clinically as a hypermetabolic crisis when a malignant hyperthermia...
Malignant hyperthermia is a subclinical myopathy, usually triggered by anesthetics and associated wi...
Modern anaesthetic techniques have resulted in the clinical presentation of malignant hyperthermia t...
Copyright © 2013 K. Sanem Cakar Turhan et al.This is an open access article distributed under the Cr...
Malignant hyperthermia is a subclinical myopathy in which general anesthesia triggers an uncontrolla...
ObjectivesMalignant hyperthermia susceptibility is an important risk factor during general anesthesi...
\s=b\Malignant hyperthermia is an autoso-mal dominant disorder with variable expressivity that is ca...
Malignant hyperthermia is a serious anesthetic complication, presenting with various manifestations,...
Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by volatile an...